Pregnancy associated plasma protein-A is preferentially expressed in plaque of patients with restenosis  by Denktas, Ali E. et al.
JACC March 6,2002 ABSTRACTS - ACCIS2002 (Angiography & Interventional Cardiology) 19A 
1054-20 Vulnerable Plaque Characterization With intravascular 
Eiastography 
Johannes, Chris L. de Korle, Frits Mastik, Chalendra Strijder, Gerard 
Paste&amp, Patrick W. Serruys, Anton F W. van der Steen, Experimental 
Echocardiography, Rotterdam. The Netherlands. 
Background: The cap of a vulnerable plaque is the weakest link, which can rupture due 
to increased strain. Intravascular elastography is a new technique to measure local strain 
in a plaque. Up to now it was unknown, how plaque morphology and strain patterns car- 
respond. 
Methods: Diseased coronary artery specimens, collected after autopsy, were evaluated 
for their morphological properties with standard intravascular ultrasound catheters and 
an elastographic workstation in a water-tank at different intraluminal pressures (60 and 
100 mmHg. 
Selected segments were stained on the presence of collagen and fat, smooth muscle 
cells and macrophages. In histology a vulnerable plaque was defined as plaque with a 
thin cap with moderate/heavy macrophage infiltration and a plaque that consisted for at 
least 40% of atheroma. In elastography, vulnerable plaque was defined as a high strain 
region on the surface of the plaque with an adjacent low strain region. In every cross-sec- 
bon a most dangerous part was defined as the part with the highest strain and compared 
to the underlying histology. Observers blinded for the outcome of the other technique, 
analyzed elastograms and histology. 
Results: In 24 diseased coronary arteries. we studied 54 crossections. 23 vulnerable 
plaques and 31 non-vulnerable plaques were found. There was a high correlation (p = 
O.OOQl) between the relationship of strain in the plaque and presence of macrophages. 
Furthermore there is an inverse relationship between strain and amount of smooth mus- 
cle cells (p = 0.031). Plaques, which are declared vulnerable in elastography, have a thin- 
ner cap than non-vulnerable plaques and a higher amount of macrophage staining (p = 
0.01). 
Conclusion: Intravascular elastography detects high strain regions in vulnerable 
plaques, which correlate with an infiltration of macrophages in caps and a decreased 
amount of smooth muscle cells. Elastographicaly vulnerable plaques have a thinner cap 
than non-vulnerable plaques. 
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1055-21 Expression of Lectin-Like LDL Receptor (LOX-l) in 
Smooth Muscle Ceils After Balloon injury 
&&&.,&J, Msaaki Miyata, Noriaki Kume, Manabu Minami, Koji Orihara, Sadatoshi 
Biro, Shinichi Minagoe. Toru Kita, Chuwa Tei, The First Department of Internal Medicine, 
Kagoshima University, Kagoshima, Japan, The Department of Geriatric Medicine, 
Graduate School of Medicine, Kyoto University, Kyoto. Japan. 
Background: Lectin-like oxidized LDL receptor-l (LOX-l) was originally isolated as an 
oxdized LDL receptor in endothelial cells. Recently, it was reported that LOX-1 was 
highly expressed in intimal smooth muscle cells (SMC), as well as macrophages, in 
advanced human atherosclerotic lesions. However, LOX-l expression in restenosis after 
vascular balloon injury has not been explored. Therefore, we investigated the expression 
of LOX-1 in the neointima and media of rabbit aoltas after balloon injury. 
Methods: Endothelium of rabbit aortas was denuded three times with a balloon catheter. 
Aortas were removed at 6, 12, and 24 hours. 2, 5, and 7 days, and 2, 4, 6. 16. and 24 
wssks after the balloon injury. Expression of LOX-l protein was analyzed by lmmunohis- 
tochemishy using a specific monoclonal antibody directed to rabbit LOX-l. LOX-l mRNA 
was measured by a quantitative reverse transcription polymerase chain reaction (RT- 
PCR) and in situ hybridization. 
Results: RT-PCR revealed that LOX-l mRNA was undetectable in non-injured aortas 
(control). In balloon-injured aortas, in contrast, LOX-1 mRNA began to be expressed at 6 
hours, peaked at 2 to 5 days (a 6.5-fold increase compared to control), and remained to 
be expressed at 24 weeks (a 4.fold increase compared to control) after the balloon injury. 
lmmunohistochemical staining showed that LOX-1 protein was not detected in non- 
injured aorta and appeared in medial SMC at 2 days after injury, before the formation of 
neointima. At 5 days after the balloon injury, neointima formation is detectable and LOX- 
1 protein was expressed in both medial and neointimal SMC. LOX-l protein continued to 
be expressed until 24 weeks after vascular injury in medial and neointimal SMC. In situ 
hybridization also showed similar time-dependent LOX-l mRNA expression in both 
medial and neointimal SMC after the balloon injury. 
Conclusion: LOX-1 was induced in both medial and naointimal SMC after vascular injury, 
suggesting that LOX-1 plays an important role in restenosis after vascular injury. 
1055-22 immunohistochemicai Staining of C-Reactive Protein 
Predicts Restenosis After Directional Coronary 
Atherectomy in Patients With Angina Pectoris 
sIshlkawa, Kinta Hatakeyama, Takuroh Imamura. Haruhiko Date, Yoshisato 
Shibata. Yutaka Hikichi, Yasushi Koiwaya. Yujiro Asada. Tanenao Eto, MiyazakiMedical 
Co//ege, Miyazaki, Japan, Miyazaki Medical Association Hospital, Miyazaki, Japan, 
Shinkoga Hospital, Kurume, Japan. 
Background: Recent evidence suggests that plasma levels of C-reactive protein (CRP) 
may be a reliable marker of the risk of restenosis aHer percutaneous coronary intewen- 
tion. Moreover recently, it has been reported that levels of both CRP mRNA and protein 
are increased in postmortem arterial plaque tissue. We investigated whether late out- 
come after directional coronary atherectomy (DCA) could be predicted by CRP staining 
in DCA samples. Methods: We examined CRP immunoreactivity in 26 DCA samples (22 
samples from primary lesion, 6 samples from restenotic lesion) from 24 patients with 
angina pectoris. Restenosis, defined as ~-50% stenosis diameter by quantitative cinean- 
giography, was present in 15 samples, whereas remaining 13 samples (<50%stenosis) 
showed no restenosis. We counted the density (numbedmm2) of total cells, SMCs, mac- 
rophages and CRP positive cells. Results: CRP immunoreactivity localized to smwth 
muscle cells (SMCs) and mactophages. The ratio of SMCs and macrophages to total 
cells were similar in samples from patients with and without restenosis (42+/-l 3% and 
42+/-17%, 17+/-10% and 19+/-12%, respectively). However, the ratio of CRP positive 
cells to total cells was significantly higher in DCA samples from patients with restenosis 
than without restenosis (20+/-9.4% vs. lo+/-6.1%, PcO.01). In addition, the ratio of CRP 
positive cells significantly correlated with late luminal loss (R=0.526, PcO.01) and loss 
index (R~0.663, P<O.OOOl) after DCA. Conclusions: CRP immunopositivity in resected 
coronary atheromatous tissue is a powerful predictor of restenosis after DCA, suggesting 
that CRP may play a role in the restenotic process after percutaneous coronary interven- 
tion. 
105.523 increased Peroxisome Proiiferator-Activated Receptor 
Gamma (PPAR) Expression in Atherectomy Specimens 
From Patients With Restenosis After Percutaneous 
Transluminai Coronary Angiopiasty 
&&&kmcQ, Tare Saito, Shuichi Oshima. Katsuo Noda. Yasushi Moriyama, Hisao 
Ogawa, Kumamoto Central Hospital, Kumamoto City, Japan, Kumamoto university, 
Kumamoto City, Japan. 
Backgroud: PPAR is a member of the nuclear receptor superfamily of ligand-activated 
transcription factors. and it has been reported that monocyteslmacrophages in human 
atherosclerotic lesions express immunostained PPAR. However, the role of PPAR in res- 
tenosis after coronary intervention is unexplored. In the present study, we examined the 
PPAR expression of atherectomy specimens by immunohistochemical analysis. Meth- 
ods: Atherectomy samples were obtained from 15 patients with restenosis after PTCA 
and 15 patients with de nova lesions of stable exertional angina by directional coronary 
atherectomy. lmmunohistochemical staining was performed on serial sections using 
monoclonal antibodies against PPAR, macrophages and smooth muscle cells (SMCs). 
Results: There were no significant differences in patients characteristics of the age, sex, 
and coronary risk factors between the restenosis and the stable exertional angina 
groups. PPAR immunoreactivity was found in all restenotic lesions obtained from patients 
after PTCA and was in 6 of the 15 patients in de nova lesions from patients with stable 
exertional angina. Moreover, there was higher density of PPAR immunostaining in rest- 
enotic lesions than in de nova sites. In restenotic lesions, neointimal thickening contained 
macrophages but was composed predominantly of SMCs, and in terms of tha cellular 
types, SMCs and macrophages expressed PPAR. Especially, immunopositive SMCs for 
PPAR were strongly observed around macrophages infiltration in restenotic sitss. In de 
nova lesions, there was less immunoreactivity of PPAR on macrophages and SMCs 
compared with restenotic sites. Conclusions: We have shown that the expression of 
PPAR was more frequently observed in restenotic lesions after PTCA than in de nova 
lesions obtained from the patients with stable exertional angina by immunohistochemis- 
try. These results indicate that local expression of PPAR may be associated with the 
mechanisms of vascular remodeling after coronary intervention. 
1055-24 Pregnancy Associated Plasma Protein-A is 
Preferentially Expressed in Plaque of Patients With 
Restenosis 
Ali F Denktas, Kristen Shogren, David R. Holmes, Antoni Bayes-Genis, Claus Oxvig, 
Michael T. Overgaard, Michael Chrfstiansen, Cheryl A. Conover, Robert S. Schwartz. 
Mayo Clinic, Rochester, Minnesota, University of Aarhus, Aarhus, Denmark. 
Background: Insulin like growth factor-l (IGF) is abundantly expressed in atheroscle- 
rotic and restenotic human arteries and is regulated by IGF binding proteins. Recently, 
pregnancy associated plasma protein (PAPP-A) has been identified as an IGF binding 
protein-4 protease associated with the injury/repair response. We sought to determine 
the expression of PAPP-A in human atherosclerosis specimens obtained by directional 
atherectomy (DCA) and its relationship with the clinical presentation of the patient. 
Methods: DCA specimens from 69 patients (pts) were immunostained for PAPP-A. The 
slides were then blindly read for the presence and extent of PAPP-A staining. PAPP-A 
presence was semi-quantitatively analyzed. Clinical data were extracted from the charts 
and cardiac catheterization laboratory database. 
Results: The study group consisted of 71169 males, mean age 64 t 11 years, 37/69 pts 
had acute coronary syndromes, 16169 had myocardial infarction, 27169 had restenotic 
lesions and 13/69 had diabetes. Sixty-two percent of the DCA specimens expressed 
PAPP-A. The patients with restenotic lesions had statistically higher PAPP-A scores than 
the other pts, as did pts with diabetes. (See figure) 
Conclusions: PAPP-A is expressed in most DCA specimens and shows increased 
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expression in restenotic plaques and DCA specimens from diabetic pts. The increased 
expression of PAPP-A in this subset of pts may suggest a mechanism for increased rest- 
enosis in diabetes through alterations in the IGF system. 
1055-25 Coincident Presence of HSP47 and BCL-2 Early 
Postarterial Trauma 
AlexanderJabs, Stefan Kramer, Dirk Skowasch, Berndt Liiderftz. Gerhard Bauriedel, 
Department of Cardio/ogx University of Bonn, Bonn, Germany 
Backgrounct Hypercellular neointima forming in response to angioplasty procedures is 
characterized by de ncvo synthesis of extracellular matrix components and low apoptotic 
cell death. Hence, we sought to analyse antiapoptotic B-cell-lymphoma (Bcl) - 2 protein 
and Heat Shock Protein (HSP) 47, an intracellular marker of collagen synthesis, in neoin- 
timal lesions. 
Methods: Balloon overstretch injury was performed in rat carotid arteries. Protein 
expression was detected by immunohistochemistty in serial sections at different times 
(7d (n=5). 14d (n=6), 26d (n=6)) post angioplasty. Uninjured contralateral carotid arteries 
served as controls. 
Results: Neointima (N) formation was seen 7 days post balloon injury in 4 of 5 treated 
arteries (mean N area 0.012 ~O.O07mm*). Early N tissue showed maximal expression of 
HSP47 (20.7 f 13.6%) and Bcl-2 (25.4 f 14.0%). With growing N area at 26d (ranging 
from 0.016mm’to O,207mm’, mean 0.130 f O.O67mm*), the expression of both proteins 
decreased significantly to 9.3 _t 8.0% (HSP47) and 5.7 f 2.5% (Bcl-2). In the 26d lesions, 
the majority of HSP47 positive cells were located close to the arterial lumen, and only 
sparse signaling was found in deep N layers. Bcl-2 expression was almost exclusively 
detectable in the layer of N cells near the luminal border. HSP47 and Bcl-2 expressions 
correlated in the N compartment (R=0.49, p=O.O4). Interestingly, HSP47 expression lev- 
els in 26d-lesions correlated to the N area quantitated by morphometric analysis 
(R=0.66, p=O.O29). 
Conclusion: Antispoptotic Bcl-2 and the collagen-specific chaperone HSP47 are both 
present and positively correlated in early neointimal lesions. While Bcl-2 might protect 
neointimal cells from cell death, HSP47 modulates the de nova synthesis of neointimal 
collagens. Persistently high HSP47 expression may significantly contribute to restenosis. 
1055-26 a& lntegrin (VLA-4) Blockade Reduces Neointimai 
Growth After Carotid Air Desiccation injury in the ApoE 
(J-) Mouse 
wG. J William Phillips, John M. Sanders, Ann C. Czamik, Klaus F. Ley, 
Ian J. Sarembock, University of Virginia, Charlottesville. Virginia. 
Background: a& integrin (VLA-4) is expressed on leukocytes and promotes inflamma- 
tory cell recruitment via ligation of VCAM-1 expressed on the luminal surface. We 
hypothesized that VLA-4 positive cells are recruited following arterial injury and that VLA- 
4 blockade would reduce neointimal formation following carotid injury in ApoE mice. 
Methods: Female ApoE (-/-) mice fed a WD underwent air desiccation injury of the right 
common carotid artery. Vessels were harvested 3 8 7 days after injury to determine VLA- 
4 expression by immunohistochemistry (IHC). Additional mice received either a VLA-4 
blocking mAb (PSZ) 200 pg ip 1 hour prior to injury (Early PSZ, n=t?) or 200 ug PS2 (Pro- 
longed PSZ. n=@ or isotype control mAb (Isotype, n=7) on days 0,3,7,10 after injury. His- 
tomorphometry was assessed at 26 days. 
Results: IHC revealed recruitment of VLA-4 positive cells early after injury (see table). 
Blockade of VLA-4 resulted in a reduction in neointimal gmwth 26 days after injury (lso- 
type=46,200~10,500 mm*; Early PS2=24,200~7,100 mm’, 50% reduction, p=.O8: Pro- 
longed PS2=13.500+3,200 mm’. 72% reduction, p=.OO5). No difference was seen in 
EEL or media areas. 
Conclusions: Carotid injury results in early recruitment of VLA-4 positive cells to the 
vessel wall. Prolonged VIA-4 blockade resulted in a significant 72% reduction in neointi- 
mal growth 26 days following injury. suggesting an important role for a4p1 integrin (VLA- 
4) in the response to arterial injury. 
Table 1. VLA-4 IHC (36 positive staining) 
Uninjured(nz4) Day 3(n=5) 
4*4 34 f 26 (p=.O7) 
Day 7&S) 
40 f 14 (p=. 005) 
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0032-l 210-Day Follow-up of the RAVEL Study: A Randomized 
Study with the Sirolimus-Eiuting Bx VELOCITYfm 
Balloon-Expandable Stent in the Treatment of Patients 
With De Novo Native Coronary Artery Lesions 
Jean, M. Perin, E. Ban Hayashi, A. Colombo, G. Schuler, P. Barragan, C. Bode. 
J. E. Sousa, M. C. Morice. Patrick W. Serruys, Thoraxcenter, Rottem’am, The 
Netherlands. 
Background: Sirolimus. a naturally occurring macrocyclic antibiotic, is a potent immuno- 
suppressive agent inducing late Gl cell cycle arrest. In a pilot study long-term (12 
months) ultrasonic follow-up (FU) demonstrated a nearfy complete abolition of neointimal 
hyperplasia. The RAVEL is a multicenter, double-blind, randomized study with a two-arm 
design assessing safety and effectiveness of the Sirolimus-eluting Bx VELOCITYb” stent 
versus the uncoated metal Bx VELOCITYtm stent (18 mm). Methods: The primary end- 
point was angiographic late loss at 6 months. The secondary endpoints were major 
adverse cardiac events target vessel revascularization, target lesion revascularization 
(TLR), restenosis rate. Inclusion criteria: patients with stable or unstable angina with sin- 
gle treatment of de nova lesions, < 16mm in length, 2.5-3.5 mm in diameter. Results: 
Between August.2000 and December,ZOOO. 236 patients were included in 19 sites in 
Europe and South America. Baseline demographics and lesion characteristics were 
equally distributed. After a loading dose, Clopidogrel or liclopidine was continued up to 6 
weeks. No acute, subacute or late thrombosis occurred. 
Conclusions: The QCA data demonstrate a near complete abolition of neo-intimal in- 
stent proliferation with zero binary restenosis in the Sirolimus group. This translated clini- 
cally into no TLR and an event-free survival of 97 %. One-year FU data will be presented. 
Resuttr at 210 days 
Reference Diameter (mm) 
MLD Post-procedure (mm) 
MLD Follow-up (mm) 
Late Loss (mm) 
Restenosis rate (%) 
TLR 
Event Free survival 
Sirolimus Control P-value 
2.60 2.64 NS 
2.43 2.41 NS 
2.42 1.64 .OOOl 
-0.01 0.60 .OOOl 
0 26 .OOOl 
0 22 .OOOl 
97 72 .ooOl 
4:15 p.m. 
0032-2 Is Bigger Better With Vascular Brachytherapy (VBT) for 
in-Stent Restenosis? impact of Optimal Final 
Angiographic Results and Predictors of Restenosis in 
990 VBT Patients 
mO. Alexandra J. Lansky, Roxana Mehran, Kartik Desai. Brian 
Proctor, Kazuyuki Shirai, Nishe Dave, Ecatarina Cristea, Martin Fahy, George Dangas, 
Gregg W. Stone, Ron Waksman, Jeffrey Moses, Martin B. Leon, Cardiovascular 
Research Foundation, New York. 
Background: After conventional PCI maximizing the final lumen dimensions predicts 
lower restenosis rates. Whether this ‘“Bigger is Better” strategy applies to pts treated with 
VBT for in-stent restenosis (ISR) is not known. Methods: Procedural and follow-up angio- 
grams of 990 pts enrolled in VBT trials were analyzed prospectively. Pts were treated 
with Gamma (N=370). Beta (N=265) radiation or placebo (N=355) for native coronary 
ISR. Results: Regression analysis was used to construct probability models for “treated 
segment’ restenosis (including edges) (fig 1) and “stent edge’ (Fig 2) restenosis based 
on the final minimal lumen diameter (MLD). Both Beta and Gamma VBT patients had 
increased probability of restenosis with smaller final MLD. By multivariable regression 
analysis independent angiographic predictors of treated segment restsnosis included 
Gamma VBT (OR=0.315, p<O.OOl) and Beta VBT (OR=0.366, pcO.OOl), lesion length 
(OR=1.045, p<O.OOl), vessel size (OR=0.651, p-zO.001) but not final MLD (OR~0.702, 
p=O.O646). Conclusions: Optimizing final angiographic results is associated with a lower 
probability of treated segment restenosis and stent edge restenosis for both Beta and 
Gamma Radiation therapy. However, restenosis after VBT appears more dependent on 
reference vessel size rather than the final treated lesion MLD. 
